Locoregional surgery in metastatic breast cancer. Do concomitant metabolic aspects have a role on the management and prognosis in this setting?
Although they cannot be considered curative, the new therapeutic integrated advances in metastatic breast cancer (MBC) have substantially improved patient outcomes. Traditionally, surgery was confined to palliation of symptomatic or ulcerating lumps.